TickerFactsScreenerDevelopers

WEST PHARMACEUTICAL SERVICES INC (WST) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2007: $108.40M2008: $87.20M2009: $83.10M2010: $110.20M2011: $91.80M2012: $161.90M2013: $230.00M2014: $255.30M2015: $274.60M2016: $203.00M2017: $235.90M2018: $337.40M2019: $439.10M2020: $615.50M2021: $762.60M2022: $894.30M2023: $853.90M2024: $484.60M2025: $791.30M$791.30M
2007Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$791.30M+63.3%
2024$484.60M-43.2%
2023$853.90M-4.5%
2022$894.30M+17.3%
2021$762.60M+23.9%
2020$615.50M+40.2%
2019$439.10M+30.1%
2018$337.40M+43.0%
2017$235.90M+16.2%
2016$203.00M-26.1%
2015$274.60M+7.6%
2014$255.30M+11.0%
2013$230.00M+42.1%
2012$161.90M+76.4%
2011$91.80M-16.7%
2010$110.20M+32.6%
2009$83.10M-4.7%
2008$87.20M-19.6%
2007$108.40M—